# NuScriptRx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nuscriptrx

- Industry: Pharmaceuticals
- Headquarters: Nashville, US
- Website: www.nuscriptrx.com
- Total disclosed funding: $29M
- Latest round: Series D (Mar 12, 2015)
- Investors on record: 7

## About

NuScriptRx is a US-based pharmaceutical company.

## Funding rounds

- Series D, Mar 12, 2015, $3.9M — Clayton Associates, Envest Private Equity, Council Capital, Launch Tennessee
- Seed, Mar 1, 2013, $1.9M — Nashville Capital Network, NEST-TN, Council & Enhanced Tennessee Fund
- Series C, Aug 27, 2012, $5M — Clayton Associates, Council Capital
- Series C, Sep 19, 2011, $8M — Council Capital, Nashville Capital Network
- Series A, May 29, 2009, $10M — Clayton Associates, Council Capital

## Investors

- Clayton Associates (https://capitalatlas.ai/funds/clayton-associates) — Series A, Series C, Series D
- Council Capital (https://capitalatlas.ai/funds/council-capital) — Series A, Series C, Series D
- Nashville Capital Network (https://capitalatlas.ai/funds/nashville-capital-network) — Series C, Seed
- NEST-TN (https://capitalatlas.ai/funds/nest-tn) — Seed
- Council & Enhanced Tennessee Fund (https://capitalatlas.ai/funds/council-enhanced-tennessee-fund) — Seed
- Envest Private Equity (https://capitalatlas.ai/funds/envest-private-equity) — Series D
- Launch Tennessee (https://capitalatlas.ai/funds/launch-tennessee) — Series D